Abstract
Randomized clinical trials in 300 patients undergoing major abdominal surgery or hip replacement arthroplasty were performed to investigate the efficacy of dihydroergotamine mesylate, heparin calcium or a combination of dihydroergotamine with heparin in preventing postoperative deep-vein thrombosis (DVT). The diagnosis of DVT was established by an uptake test using fibrinogen labeled with 125I. In patients undergoing hip replacement, phlebography was also employed to confirm or refute the presence of isotopic thrombi. The combination of dihydroergotamine and heparin is probably more effective than heparin or dihydroergotamine alone in preventing DVT.

This publication has 1 reference indexed in Scilit: